Global Duchenne Muscular Dystrophy Market

Duchenne Muscular Dystrophy Market Size, Share, Growth Analysis, By Therapy(Mutation Suppression, Exon Skipping Approach, Others Therapies), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Forecast 2025-2032

Report ID: SQSG35I2036 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 63 | Figures: 75

Duchenne Muscular Dystrophy Market News

  • In June 2022, Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines.
  • In Feb 2022, Recipharm acquires Portuguese CDMO as part of biologics expansion. CDMO GenIbet, specializes in producing biological clinical trial material and other viral vectors, for an undisclosed price.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Duchenne Muscular Dystrophy Market size was valued at USD 1362.61 Million in 2023 and is poised to grow from USD 1426.65 Million in 2024 to USD 2156.94 Million by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

Global duchenne muscular dystrophy market is competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Pfizer Inc.', 'PTC Therapeutics Inc.', 'Sarepta Therapeutics', 'Santhera Pharmaceuticals', 'Solid Biosciences', 'Catabasis Pharmaceuticals', 'Summit Therapeutics', 'NS Pharma, Inc.', 'Wave Life Sciences', 'BioMarin Pharmaceutical Inc.', 'ReveraGen BioPharma Inc.', 'Bristol-Myers Squibb', 'Roche Holding AG', 'Daiichi Sankyo Company, Limited', 'Vertex Pharmaceuticals', 'Italfarmaco S.p.A.', 'Biogen', 'Ultragenyx Pharmaceutical Inc.', 'FibroGen', 'Marathon Pharmaceuticals, LLC'

Prevalence of duchenne muscular dystrophy is on the rise, and factors that are driving its market growth include increased awareness campaigns about the disorder, the development of mutation-specific therapies, the rise in product pipelines, the introduction of therapies like Exondys51 and Translarna, and the use of corticosteroid-based anti-inflammatory drugs.

The introduction of novel pharmaceuticals and treatments, disease-modifying treatments, significant backing from numerous firms for drug research, and support from patient advocacy groups on the regulatory approval process are the main factors driving the global market for duchenne muscular dystrophy.

North America dominated the global duchenne muscular dystrophy market. The market in North America is expected to expand as a result of a number of important factors, including the rising prevalence of muscular dystrophy in the region, FDA drug approval, strong healthcare infrastructure supported by supportive government regulations, and medical reimbursement in the region and due to anticipated product launches.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

D-psicose Market
Buy Now GET FREE SAMPLE
Muscle Stimulator Market
Buy Now GET FREE SAMPLE
Dravet Syndrome Market
Buy Now GET FREE SAMPLE
Sciatica Market
Buy Now GET FREE SAMPLE
Dimethyl Carbonate (DMC) Market
Buy Now GET FREE SAMPLE
Muscle Relaxant Drugs Market
Buy Now GET FREE SAMPLE
Muscle Stimulation Devices Market
Buy Now GET FREE SAMPLE
Cartilage Repair Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Duchenne Muscular Dystrophy Market

Report ID: SQSG35I2036

$5,300
BUY NOW GET FREE SAMPLE